A Health Economic analysis was conducted across three diverse healthcare systems. The analysis reported lower total healthcare costs for Cryoballoon compared to radiofrequency over the trial period.†
Cryoballoon was the greater value to healthcare systems in the FIRE AND ICE trial and may enable global healthcare systems to treat more patients within existing healthcare budgets.
Health Economic Analysis Methods
Trial-period Health Economic Supplementary Analysis from a Payer Perspective
Cost Assignment Methods
Overall payer costs were significantly lower in the Cryoballoon group compared to the radiofrequency group (RFC) and persisted across three healthcare systems.
Total trial period† cost savings:
Higher RFC costs were driven by differences in repeat ablations and CV hospitalizations
TRIAL PERIOD COST DIFFERENCES BY HEALTHCARE SYSTEM
† Mean follow-up: 1.5 years
Maximum follow-up: 33 months